MEDICUS PHARMA LTD (MDCX:NASDAQ)
$0.1545 0.0024 (1.5779%)
Analysed MEDICUS PHARMA LTD (MDCX:NASDAQ) News Sources
Medicus Pharma receives FDA clearance to begin registrational SkinJect study for Gorlin syndrome
27-07-2026
proactiveinvestors.com
Medicus Pharma cleared by FDA for registrational Phase 2b trial in patients with Gorlin Syndrome
27-07-2026
yahoo.com
Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI
01-08-2026
proactiveinvestors.com
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
12-08-2026
yahoo.com
Medicus Pharma advances pipeline during Q2 with key milestones
13-08-2026
proactiveinvestors.com
Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy
08-09-2026
advfn.com
Medicus Pharma reorients around new cancer drug candidate, sharpens focus for other programs
08-09-2026
proactiveinvestors.com
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
10-09-2026
yahoo.com
Medicus Pharma reports positive Phase 2 data for SkinJect in skin cancer treatment
10-09-2026
proactiveinvestors.com
Medicus Pharma Identifies 200 µg SkinJect Patch as Lead Development Dose After Phase 2 Study
10-09-2026
advfn.com
What is the current price of MEDICUS PHARMA LTD (MDCX:NASDAQ)?
The current price of MEDICUS PHARMA LTD (MDCX:NASDAQ) is $0.1545.
MEDICUS PHARMA LTD (MDCX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MEDICUS PHARMA LTD (MDCX:NASDAQ) since the previous trading day is $0.0024.
MEDICUS PHARMA LTD (MDCX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MEDICUS PHARMA LTD (MDCX:NASDAQ) since the previous trading day is 1.5779%.
What is the most recent average sentiment score for MEDICUS PHARMA LTD (MDCX:NASDAQ)?
The most recent average sentiment score for MEDICUS PHARMA LTD (MDCX:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for MEDICUS PHARMA LTD (MDCX:NASDAQ)?
The most recent sentiment for MEDICUS PHARMA LTD (MDCX:NASDAQ) is .
SEC-8K** Filing Available For MEDICUS PHARMA LTD (MDCX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.